Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and ...

This is Buc-ee’s El Paso County’s statement that no Buc-ee’s application has been filed misses the point entirely. What is before the county is a Boundary Line Adjustment (BLA, File No. EXBL261) — a ...

In South Africa, as in many places, pharmaceutical companies are not free to change medicine prices as they wish. Dr Andy Gray unpacks how medicines prices are regulated in the country and considers ...

Mental health disorders--including depression, anxiety, PTSD, and bipolar disorder--continue to represent one of the largest and fastest-growing ...

While major cases of fraud have wiped confidence in the country’s startups, there are still opportunities in South-east ...

Produced from used motor oil through Vertex’s integrated collection network, the VTX-R6 supports applications requiring ...

Vertex Flooring Presents High-Performance SPC Flooring Designed for Stability, Style, and Durability HOLLISTON, MA, ...

Vertex Pharmaceuticals (Nasdaq: NASDAQ:VRTX) and Ono Pharmaceutical (OTCMKTS: OTCPK:OPHLY) have announced an exclusive collaboration, for the development and commercialization of Vertex's povetacicept ...

Christopher Young: Welcome everyone and thank you for joining us. It's great to join you on my first earnings conference call as President and CEO of Vertex. Our financial results for the fourth ...

Vertex Pharmaceuticals is downgraded to Hold ahead of Q4 earnings due to underwhelming growth from key new drugs. Journavx and Casgevy sales remain niche, raising doubts about their ability to drive ...

AI models are pushing against three frontiers at once: raw intelligence, response time, and a third quality you might call ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...